Mirum Pharmaceuticals Quote - MIRM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

42.65

Bid

41.50

Offer

46.52

Volume

273,431

41.58 Day's Range 42.845

23.14 52 Week Range 48.89

Market Cap

2.047B

Previous Close

42.39

Open

41.95

Last Trade

42.65

Last Trade Time

Financial Volume

US$ 11,599,769

VWAP

42.423

Average Volume (3m)

360,792

Shares Outstanding

48,004,582

Dividend Yield

PE Ratio

-12.52

Earnings Per Share (EPS)

-3.4

Revenue

186.37M

Net Profit

-163.42M

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Dover, Delaware, USA

Founded

Mirum Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MIRM. The last closing price for Mirum Pharmaceuticals was US$42.39. Over the last year, Mirum Pharmaceuticals shares have traded in a share price range of US$ 23.14 to US$ 48.89.

Mirum Pharmaceuticals currently has 48,004,582 shares in issue. The market capitalisation of Mirum Pharmaceuticals is US$2.03 billion. Mirum Pharmaceuticals has a price to earnings ratio (PE ratio) of -12.52.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.49	-1.13583681038	43.14	45.03	41.6	482624	43.06527279	CS
4	1.13	2.72157996146	41.52	47.08	41.0504	365375	44.02916858	CS
12	3.62	9.27491673072	39.03	48.89	37.51	360792	41.82738998	CS
26	15.05	54.5289855072	27.6	48.89	27.1	531418	39.07929118	CS
52	15.28	55.8275484107	27.37	48.89	23.14	550179	32.87823478	CS
156	27.84	187.981093856	14.81	48.89	14.63	440012	28.38566582	CS
260	25.31	145.963091119	17.34	48.89	9.14	317239	26.69862402	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUKKNukkleus Inc	US$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	US$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	US$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	US$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	US$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	US$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	US$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	US$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	US$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	US$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	US$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.335 (-36.79%)	1B
GOEVCanoo Inc	US$ 0.118 (7.08%)	382.65M
NVDANVIDIA Corporation	US$ 130.39 (-1.22%)	251.71M
XTIAXTI Aerospace Inc	US$ 0.0442 (8.33%)	221.41M